Gentiluomo M, Corradi C, Apadula L, Comandatore A, Lauri G, Rossi G
Cancer. 2024; 131(1):e35678.
PMID: 39639588
PMC: 11694541.
DOI: 10.1002/cncr.35678.
Chang Y, Head S, Harrison T, Yu Y, Huff C, Pasaniuc B
medRxiv. 2024; .
PMID: 39574839
PMC: 11581093.
DOI: 10.1101/2024.10.29.24316388.
Sun Y, Hu C, Hu S, Xu H, Gong J, Wu Y
Cancer Med. 2024; 13(21):e70388.
PMID: 39526476
PMC: 11551786.
DOI: 10.1002/cam4.70388.
Fernando A, Liyanage C, Srinivasan S, Panchadsaram J, Rothnagel J, Clements J
Commun Med (Lond). 2024; 4(1):224.
PMID: 39487222
PMC: 11530646.
DOI: 10.1038/s43856-024-00613-9.
Daniel N, Farinella R, Chatziioannou A, Jenab M, Mayen A, Rizzato C
Sci Rep. 2024; 14(1):25144.
PMID: 39448785
PMC: 11502931.
DOI: 10.1038/s41598-024-77431-5.
Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer.
Pergolizzi R, Brower S
Int J Mol Sci. 2024; 25(19).
PMID: 39409171
PMC: 11476914.
DOI: 10.3390/ijms251910843.
Allelic effects on expression likely mediated by JunB/D underlie a PDAC GWAS signal at chr1p36.33.
Connelly K, Hullin K, Abdolalizadeh E, Zhong J, Eiser D, OBrien A
medRxiv. 2024; .
PMID: 39371158
PMC: 11451706.
DOI: 10.1101/2024.09.16.24313748.
Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization.
Galvez-Montosa F, Peduzzi G, Sanchez-Maldonado J, Ter Horst R, Cabrera-Serrano A, Gentiluomo M
Int J Cancer. 2024; 156(2):339-352.
PMID: 39319538
PMC: 11578083.
DOI: 10.1002/ijc.35196.
Association of telomerase reverse transcriptase gene rs10069690 variant with cancer risk: an updated meta-analysis.
Zhou C, Yang Y, Shen L, Wang L, Zhang J, Wu X
BMC Cancer. 2024; 24(1):1059.
PMID: 39192222
PMC: 11350973.
DOI: 10.1186/s12885-024-12833-2.
A novel heuristic of rigid docking scores positively correlates with full-length nuclear receptor LRH-1 regulation.
Haratipour Z, Foutch D, Blind R
Comput Struct Biotechnol J. 2024; 23:3065-3080.
PMID: 39185441
PMC: 11342790.
DOI: 10.1016/j.csbj.2024.07.021.
The updated relationship between the cleft‑lip and palate transmembrane protein‑1‑like rs401681 and lung cancer risk: A systematic review and meta‑analysis.
Fang Z, Zhao G, Wang Y, Li F, Ding Z
Mol Clin Oncol. 2024; 21(4):70.
PMID: 39113849
PMC: 11304168.
DOI: 10.3892/mco.2024.2768.
KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis.
Sigafoos A, Tolosa E, Carr R, Fernandez-Barrena M, Almada L, Pease D
Cancer Res Commun. 2024; 4(7):1677-1689.
PMID: 38896052
PMC: 11232480.
DOI: 10.1158/2767-9764.CRC-23-0464.
Association between PDCD6-VNTR polymorphism and urinary cancer susceptibility.
Yang G, Kim M, Jeong M, Lee S, Choi Y, Nam J
Genes Genomics. 2024; 46(11):1281-1291.
PMID: 38850471
DOI: 10.1007/s13258-024-01523-9.
Identification of biomarkers and potential therapeutic targets for pancreatic cancer by proteomic analysis in two prospective cohorts.
Lyu J, Jiang M, Zhu Z, Wu H, Kang H, Hao X
Cell Genom. 2024; 4(6):100561.
PMID: 38754433
PMC: 11228889.
DOI: 10.1016/j.xgen.2024.100561.
Polycyclic Aromatic Hydrocarbons and Pancreatic Cancer: An Analysis of the Blood Biomarker, -1,-2,3,-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and Selected Metabolism Gene SNPs.
Nguyen S, Carlson H, Yoder A, Bamlet W, Oberg A, Petersen G
Nutrients. 2024; 16(5).
PMID: 38474816
PMC: 10935191.
DOI: 10.3390/nu16050688.
Physical Activity, Sedentary Behavior, and Pancreatic Cancer Risk: A Mendelian Randomization Study.
Gentiluomo M, Dixon-Suen S, Farinella R, Peduzzi G, Canzian F, Milne R
J Endocr Soc. 2024; 8(4):bvae017.
PMID: 38425433
PMC: 10904288.
DOI: 10.1210/jendso/bvae017.
Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study.
Yamazaki H, Streicher S, Wu L, Fukuhara S, Wagner R, Heni M
Cell Rep Med. 2024; 5(2):101391.
PMID: 38280379
PMC: 10897551.
DOI: 10.1016/j.xcrm.2023.101391.
Exploring the Relationship between -MS2 Variants and Susceptibility to Bladder Cancer.
Jeong M, Mun J, Yang G, Kim M, Lee S, Choi Y
Genes (Basel). 2024; 15(1).
PMID: 38254939
PMC: 10815179.
DOI: 10.3390/genes15010050.
An Integrative Pancreatic Cancer Risk Prediction Model in the UK Biobank.
Ke T, Lophatananon A, Muir K
Biomedicines. 2023; 11(12).
PMID: 38137427
PMC: 10740416.
DOI: 10.3390/biomedicines11123206.
Association of genetic risk and lifestyle with pancreatic cancer and their age dependency: a large prospective cohort study in the UK Biobank.
Zeng L, Wu Z, Yang J, Zhou Y, Chen R
BMC Med. 2023; 21(1):489.
PMID: 38066552
PMC: 10709905.
DOI: 10.1186/s12916-023-03202-0.